Vireo Growth Inc.
Pharmaceutical company · Minneapolis, Minnesota, United States · OTC: VREOF
Vireo Growth Inc. is a pharmaceutical company headquartered in Minneapolis, Minnesota, United States. Its shares trade on OTC under the ticker VREOF. It has reported private securities offerings to the US SEC, most recently $90,625 sold in a notice filed in 2023.
Vireo Growth at a glance
What does Vireo Growth do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $90,625 sold (2023).
Frequently asked questions about Vireo Growth
Where is Vireo Growth headquartered?
Vireo Growth Inc. is headquartered in Minneapolis, Minnesota, United States.
What does Vireo Growth do?
Vireo Growth Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Vireo Growth a public company?
Yes. Vireo Growth Inc. trades on OTC under the ticker VREOF.
Similar companies
- DiaMedica Therapeutics Inc.Minneapolis, Minnesota, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences